Tassopoulos NC - Search Results

1

Significance of IgM anti-HCV core level in chronic hepatitis C.

Papatheodoridis GV, Delladetsima JK, Katsoulidou A, Sypsa V, Albrecht M, Michel G, Hatzakis A, Tassopoulos NC. Papatheodoridis GV, et al. Among authors: tassopoulos nc. J Hepatol. 1997 Jul;27(1):36-41. doi: 10.1016/s0168-8278(97)80277-2. J Hepatol. 1997. PMID: 9252071

2

Significance of liver histology in HBsAg-positive, IgM anti-HBc-negative acute hepatitis B virus-related hepatitis.

Delladetsima I, Papatheodoridis GV, Tiniakos DG, Hatzakis A, Tassopoulos NC. Delladetsima I, et al. Among authors: tassopoulos nc. Histopathology. 2012 Nov;61(5):881-8. doi: 10.1111/j.1365-2559.2012.04294.x. Epub 2012 Aug 8. Histopathology. 2012. PMID: 22882633

3

Early prediction of successful alpha-interferon therapy of chronic hepatitis C by core-IgM antibodies to hepatitis C virus.

Tassopoulos NC, Hatzakis AE, Papatheodoridis GV, Karvountzis G, Troonen H, Lennartz L. Tassopoulos NC, et al. J Hepatol. 1994 Feb;20(2):305-6. doi: 10.1016/s0168-8278(05)80074-1. J Hepatol. 1994. PMID: 7516362 No abstract available.

4

Prevalence of antibodies to hepatitis C virus in Greek patients with chronic liver disease.

Papatheodoridis GV, Delladetsima I, Koutelou M, Katsoulidou A, Hatzakis A, Tassopoulos NC. Papatheodoridis GV, et al. Among authors: tassopoulos nc. J Hepatol. 1994 Feb;20(2):311. doi: 10.1016/s0168-8278(05)80079-0. J Hepatol. 1994. PMID: 7516364 No abstract available.

5

Prevalence of antibodies to hepatitis C virus in Greek patients with chronic liver disease.

Papatheodoridis GV, Delladetsima I, Koutelou M, Katsoulidou A, Hatzakis A, Tassopoulos NC. Papatheodoridis GV, et al. Among authors: tassopoulos nc. J Hepatol. 1994 Jun;20(6):843. doi: 10.1016/s0168-8278(05)80160-6. J Hepatol. 1994. PMID: 7523484 No abstract available.

6

Clinicopathological assessment of hepatitis C virus infection in parenteral drug abusers.

Papatheodoridis GV, Delladetsima J, Verghisi-Nikolakaki S, Malliori M, Krystallis A, Hatzakis A, Tassopoulos NC. Papatheodoridis GV, et al. Among authors: tassopoulos nc. Am J Gastroenterol. 1995 Oct;90(10):1843-6. Am J Gastroenterol. 1995. PMID: 7572906

7

Fulminant hepatitis due to Epstein-Barr virus infection.

Papatheodoridis GV, Delladetsima JK, Kavallierou L, Kapranos N, Tassopoulos NC. Papatheodoridis GV, et al. Among authors: tassopoulos nc. J Hepatol. 1995 Sep;23(3):348-50. J Hepatol. 1995. PMID: 8551000

8

Hepatitis E virus infection in a cohort of patients with acute non-A, non-B hepatitis.

Psichogiou MA, Tassopoulos NC, Papatheodoridis GV, Tzala E, Klarmann R, Witteler H, Schlauder GG, Troonen H, Hatzakis A. Psichogiou MA, et al. Among authors: tassopoulos nc. J Hepatol. 1995 Dec;23(6):668-73. doi: 10.1016/0168-8278(95)80032-8. J Hepatol. 1995. PMID: 8750165

9

Comparative efficacy of a high or low dose of interferon alpha 2b in chronic hepatitis C: a randomized controlled trial.

Tassopoulos NC, Karvountzis G, Touloumi G, Delladetsima JK, Papatheodoridis GV, Katsoulidou A, Retalis G, Hatzakis A. Tassopoulos NC, et al. Am J Gastroenterol. 1996 Sep;91(9):1734-8. Am J Gastroenterol. 1996. PMID: 8792690 Clinical Trial.

10

Biochemical and virological response of chronic hepatitis C after treatment with interferon-alpha for 6 or 12 months: predictors of sustained remission.

Papatheodoridis GV, Katsoulidou A, Touloumi G, Delladetsima JK, Hatzakis A, Tassopoulos NC. Papatheodoridis GV, et al. Among authors: tassopoulos nc. Eur J Gastroenterol Hepatol. 1996 May;8(5):469-75. Eur J Gastroenterol Hepatol. 1996. PMID: 8804876 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters